Publicacions en col·laboració amb investigadors/es de Centro de Investigacion Biomedica en Red de Salud Mental (34)

2025

  1. Machine Learning for the Identification of Biomarker and Risk Factors associated with Depression in Adult Population: Preliminary Results on a Small Cohort

    Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)

2024

  1. Association between neutrophil to lymphocyte ratio and inflammatory biomarkers in patients with a first episode of psychosis

    Journal of Psychiatric Research, Vol. 172, pp. 334-339

  2. Inflammatory profiles in women with eating disorder: Linking inflammatory biomarkers to clinical phenotypes

    Psychoneuroendocrinology, Vol. 162

  3. N-acetylcysteine during critical neurodevelopmental periods prevents behavioral and neurochemical deficits in the Poly I:C rat model of schizophrenia

    Translational Psychiatry, Vol. 14, Núm. 1

  4. THC improves behavioural schizophrenia-like deficits that CBD fails to overcome: a comprehensive multilevel approach using the Poly I:C maternal immune activation

    Psychiatry Research, Vol. 331

  5. Transdiagnostic inflammatory and oxidative biomarkers with predictive capacity of self-injurious behavior in impulsive and unstable disorders

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 130

2023

  1. Association of Prolactin, Oxytocin, and Homocysteine With the Clinical and Cognitive Features of a First Episode of Psychosis Over a 1-Year Follow-Up

    International Journal of Neuropsychopharmacology, Vol. 26, Núm. 11, pp. 796-807

  2. Inflammatory and oxidative endophenotypes in borderline personality disorder: A biomarker cluster analysis

    World Journal of Biological Psychiatry, Vol. 24, Núm. 7, pp. 587-594

  3. Neighborhood Vulnerability and Disability in First Episode of Psychosis: A Multilevel Study

    The Journal of clinical psychiatry, Vol. 84, Núm. 2

  4. Neuroimaging Revealed Long-Lasting Glucose Metabolism Changes to Morphine Withdrawal in Rats Pretreated with the Cannabinoid Agonist CP-55,940 during Periadolescence

    European Neuropsychopharmacology, Vol. 69, pp. 60-76

  5. Oxidative stress and inflammatory pathways in female eating disorders and borderline personality disorders with emotional dysregulation as linking factors with impulsivity and trauma

    Psychoneuroendocrinology, Vol. 158

2022

  1. Dysfunction of Inflammatory Pathways and Their Relationship With Psychological Factors in Adult Female Patients With Eating Disorders

    Frontiers in Pharmacology, Vol. 13

  2. Inflammation biomarkers in suicide attempts and their relation to abuse, global functioning and cognition

    World Journal of Biological Psychiatry, Vol. 23, Núm. 4, pp. 307-317

  3. Reduced glucocorticoid receptor expression in blood mononuclear cells of patients with borderline personality disorder

    Frontiers in Psychiatry, Vol. 13

  4. Sphk2 deletion is involved in structural abnormalities and Th17 response but does not aggravate colon inflammation induced by sub-chronic stress

    Scientific Reports, Vol. 12, Núm. 1

  5. The Influence of Oxytocin and Prolactin During a First Episode of Psychosis: The Implication of Sex Differences, Clinical Features, and Cognitive Performance

    The international journal of neuropsychopharmacology, Vol. 25, Núm. 8, pp. 666-677

  6. The effects of mango leaf extract during adolescence and adulthood in a rat model of schizophrenia

    Frontiers in Pharmacology, Vol. 13

2021

  1. A Characterization of the Effects of Minocycline Treatment during Adolescence on Structural, Metabolic, and Oxidative Stress Parameters in a Maternal Immune Stimulation Model of Neurodevelopmental Brain Disorders

    International Journal of Neuropsychopharmacology, Vol. 24, Núm. 9, pp. 734-748

  2. Analysis of molecular networks in the cerebellum in chronic schizophrenia: Modulation by early postnatal life stressors in murine models

    International Journal of Molecular Sciences, Vol. 22, Núm. 18

  3. Cannabidiol antidepressant-like effect in the lipopolysaccharide model in mice: Modulation of inflammatory pathways

    Biochemical Pharmacology, Vol. 185